Maxim Dives 61 Pct on Drug Trial Result (Reuters) Reuters - Maxim Pharmaceuticals Inc.\ said a trial to confirm the benefit of its Ceplene\drug failed to show an improvement in survival rates for\patients with liver cancer, sending its shares plunging on\Monday.